147 related articles for article (PubMed ID: 12819218)
1. Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats.
Danielson LA; Conrad KP
J Appl Physiol (1985); 2003 Oct; 95(4):1509-14. PubMed ID: 12819218
[TBL] [Abstract][Full Text] [Related]
2. Relaxin is a potent renal vasodilator in conscious rats.
Danielson LA; Sherwood OD; Conrad KP
J Clin Invest; 1999 Feb; 103(4):525-33. PubMed ID: 10021461
[TBL] [Abstract][Full Text] [Related]
3. Effects of relaxin on systemic arterial hemodynamics and mechanical properties in conscious rats: sex dependency and dose response.
Debrah DO; Conrad KP; Danielson LA; Shroff SG
J Appl Physiol (1985); 2005 Mar; 98(3):1013-20. PubMed ID: 15489259
[TBL] [Abstract][Full Text] [Related]
4. Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats.
Danielson LA; Kercher LJ; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2000 Oct; 279(4):R1298-304. PubMed ID: 11003996
[TBL] [Abstract][Full Text] [Related]
5. Vascular matrix metalloproteinase-9 mediates the inhibition of myogenic reactivity in small arteries isolated from rats after short-term administration of relaxin.
Jeyabalan A; Novak J; Doty KD; Matthews J; Fisher MC; Kerchner LJ; Conrad KP
Endocrinology; 2007 Jan; 148(1):189-97. PubMed ID: 17053025
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human relaxin (rhRLX) modifies systemic arterial properties in conscious rats irrespective of gender, but in a biphasic fashion.
Debrah DO; Conrad KP; Novak J; Danielson LA; Shroff SG
Ann N Y Acad Sci; 2005 May; 1041():155-62. PubMed ID: 15956701
[TBL] [Abstract][Full Text] [Related]
7. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.
Debrah DO; Conrad KP; Jeyabalan A; Danielson LA; Shroff SG
Hypertension; 2005 Oct; 46(4):745-50. PubMed ID: 16172427
[TBL] [Abstract][Full Text] [Related]
8. Relaxin improves renal function and histology in aging Munich Wistar rats.
Danielson LA; Welford A; Harris A
J Am Soc Nephrol; 2006 May; 17(5):1325-33. PubMed ID: 16597680
[TBL] [Abstract][Full Text] [Related]
9. Evidence against the hypothesis that endothelial endothelin B receptor expression is regulated by relaxin and pregnancy.
Kerchner LJ; Novak J; Hanley-Yanez K; Doty KD; Danielson LA; Conrad KP
Endocrinology; 2005 Jun; 146(6):2791-7. PubMed ID: 15761039
[TBL] [Abstract][Full Text] [Related]
10. Influence of recombinant human relaxin on renal hemodynamics in healthy volunteers.
Smith MC; Danielson LA; Conrad KP; Davison JM
J Am Soc Nephrol; 2006 Nov; 17(11):3192-7. PubMed ID: 17035617
[TBL] [Abstract][Full Text] [Related]
11. Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats.
Conrad KP; Debrah DO; Novak J; Danielson LA; Shroff SG
Endocrinology; 2004 Jul; 145(7):3289-96. PubMed ID: 15198972
[TBL] [Abstract][Full Text] [Related]
12. Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats.
Novak J; Ramirez RJ; Gandley RE; Sherwood OD; Conrad KP
Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R349-55. PubMed ID: 12121847
[TBL] [Abstract][Full Text] [Related]
13. Relaxin-induced changes in renal sodium excretion in the anesthetized male rat.
Bogzil AH; Eardley R; Ashton N
Am J Physiol Regul Integr Comp Physiol; 2005 Jan; 288(1):R322-8. PubMed ID: 15388493
[TBL] [Abstract][Full Text] [Related]
14. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries.
Jeyabalan A; Novak J; Danielson LA; Kerchner LJ; Opett SL; Conrad KP
Circ Res; 2003 Dec; 93(12):1249-57. PubMed ID: 14593002
[TBL] [Abstract][Full Text] [Related]
15. Relaxin-induced changes in renal function and RXFP1 receptor expression in the female rat.
Bogzil AH; Ashton N
Ann N Y Acad Sci; 2009 Apr; 1160():313-6. PubMed ID: 19416210
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.
Tozzi CA; Poiani GJ; McHugh NA; Shakarjian MP; Grove BH; Samuel CS; Unemori EN; Riley DJ
Pulm Pharmacol Ther; 2005; 18(5):346-53. PubMed ID: 15939313
[TBL] [Abstract][Full Text] [Related]
17. The effect of relaxin infusion on prolactin and growth hormone secretion in monkeys.
Bethea CL; Cronin MJ; Haluska GJ; Novy MJ
J Clin Endocrinol Metab; 1989 Nov; 69(5):956-62. PubMed ID: 2793997
[TBL] [Abstract][Full Text] [Related]
18. First clinical experience with intravenous recombinant human relaxin in compensated heart failure.
Dschietzig T; Teichman S; Unemori E; Wood S; Boehmer J; Richter C; Baumann G; Stangl K
Ann N Y Acad Sci; 2009 Apr; 1160():387-92. PubMed ID: 19416226
[TBL] [Abstract][Full Text] [Related]
19. Impaired vascular responses to relaxin in diet-induced overweight female rats.
van Drongelen J; van Koppen A; Pertijs J; Gooi JH; Parry LJ; Sweep FC; Lotgering FK; Smits P; Spaanderman ME
J Appl Physiol (1985); 2012 Mar; 112(6):962-9. PubMed ID: 22174401
[TBL] [Abstract][Full Text] [Related]
20. Relaxin is essential for renal vasodilation during pregnancy in conscious rats.
Novak J; Danielson LA; Kerchner LJ; Sherwood OD; Ramirez RJ; Moalli PA; Conrad KP
J Clin Invest; 2001 Jun; 107(11):1469-75. PubMed ID: 11390429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]